Farm Animal Drugs Market Growth and Analysis 2028
农场动物药物市场预计将从 2021 年的 182.5309 亿美元增长到 2028 年的 283.6408 亿美元;预计 2021 年至 2028 年的复合年增长率为6.5 %。
药物在维持农场动物健康和改善农场生产者的经济状况方面发挥着关键作用。随着人们寻求营养丰富、无病害的食品,提高生产力的需求变得越来越重要。药理活性化合物有助于防止疾病从动物传染给人类。农场动物的健康在很大程度上受到药物使用的影响。农场动物药物是用于医疗实践的药物,用于诊断、治愈、缓解、治疗或预防可能影响牲畜的疾病。这些药物是根据其对维持农场动物健康的重要性而严格按照要求使用的。简而言之,农场动物药物是支持全球畜牧业增长的关键因素。农场动物止痛药使用量的增加、食源性疾病和感染发病率的上升以及对优质药品和食品安全的需求激增等因素推动了农场动物药物市场的增长。然而,药物对动物的副作用以及与农场动物药物使用相关的严格政府规定阻碍了市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
农场动物药物市场:
复合年增长率(2021 - 2028 年)6.5%- 2021 年市场规模
182.5 亿美元 - 2028 年市场规模
283.6 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 菲布罗动物保健公司
- 硕腾公司
- 塞瓦
- 礼来
- 维克
- INTAS 制药有限公司
- Alembic 制药有限公司
- 勃林格殷格翰国际有限公司
- 默沙东动物保健
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 抗感染
- 杀寄生虫剂
- 消炎(药
- 麻醉药
- 止痛药
- 激素及相关产品
- 其他的
- 家畜和马
- 口服
- 肠外
- 主题
- 其他的
- 兽医医院
- 兽医诊所
- 药房和药店
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场洞察
农场动物止痛药使用量的不断增长促进了农场动物药物市场的增长
农场动物的疼痛通常与常见的生产疾病有关,例如跛足和乳腺炎,并通过常规饲养实践(例如阉割和断尾)带给动物。疼痛会导致行为、自主神经和神经内分泌变化;并引发负面情感状态,损害动物福利,损害农业的盈利能力。
控制疼痛对所有动物的健康都至关重要。2018 年,美国食品药品监督管理局 (FDA) 批准了第一种用于食用动物的止痛药。蹄腐病是所有年龄和品种的牛出现疼痛和跛行的常见原因。这种疾病见于谷仓和牛棚饲养的牛以及牧场上的牛。Banamine Transdermal 被批准用于治疗与牛蹄腐病相关的疼痛,并且只能凭处方获得。FDA 兽医中心通过确保动物获得安全有效的药物来促进和保护动物健康。与制药公司合作开发和批准用于控制所有动物(包括食用动物)疼痛的药物是这一使命不可或缺的一部分。
畜牧业中有几种常规做法需要对动物进行有效的疼痛管理。一些导致农场动物疼痛的常规程序包括阉割、去角或去角和烙印。用于控制农场动物疼痛的最常见药物包括非甾体抗炎药 (NSAID)、局部麻醉剂、α2-激动剂和阿片类药物。有效管理食用动物的疼痛已逐渐成为全球消费者关注的问题,因此引起了监管机构的高度关注。因此,全球畜牧业正在不断发展新的做法,并使用标签外止痛药,同时考虑到动物福利和盈利能力。因此,这导致利多卡因、赛拉嗪、地托咪啶、美托咪啶、氯胺酮、托芬那酸、丁丙诺啡等止痛药在农场动物的一般疼痛管理实践中的使用量显著增加。
消费者越来越意识到并关注食用动物的福利。这给供应商带来了压力,他们必须确保进入其系统的动物得到人道对待。正在采取措施满足这种需求。美国仅批准了一种药物用于控制非哺乳牛的趾间蜂窝织炎(腐蹄病)疼痛。因此,在牛的选择性手术(例如去角和阉割)中使用药物进行疼痛管理,或在哺乳奶牛和猪中使用镇痛药被视为标签外用药。它根据《兽药使用法》的说明进行监管。氟尼辛、美洛昔康和酮洛芬是非甾体抗炎药,在农场镇痛方面有支持性研究。市场上有几种产品可用于缓解动物疼痛,例如局部和区域麻醉剂、阿片类药物和非甾体抗炎药 (NSAID)。
基于产品类型的洞察
根据产品类型,农场动物药物市场细分为抗感染药、杀虫剂、抗炎药、麻醉药、镇痛药、激素及相关产品等。杀虫剂部分在 2021 年占据最大市场份额,预计在预测期内将实现最高复合年增长率。
基于动物类型的见解
根据动物类型,农场动物药物市场分为家畜和马。家畜部分在 2021 年占据了最大的市场份额,为 90.77%,预计在预测期内仍将保持主导地位。
基于给药途径的见解
根据给药途径,农场动物药物市场分为口服、肠外、外用和其他。口服药物在 2021 年占据了最大的市场份额,为 90.77%,预计在预测期内仍将保持主导地位。
基于分销渠道的洞察
根据分销渠道,农场动物药物市场细分为兽医医院、兽医诊所、药房和药店等。兽医医院部分在 2021 年占据了最大的市场份额,而兽医诊所部分的市场预计在预测期内将以 6.9% 的复合年增长率增长。
在农场动物药物市场运营的各家公司正在采用产品发布、并购、合作、产品创新和产品组合扩展等策略,以扩大其全球影响力、维护品牌名称并满足最终用户日益增长的需求。
农场动物药物市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 182.5亿美元 |
2028 年市场规模 | 283.6亿美元 |
全球复合年增长率(2021 - 2028) | 6.5% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
农场动物药物市场 – 按产品类型
- 抗感染
- 杀寄生虫剂
- 消炎(药
- 麻醉药
- 止痛药
- 激素及相关产品
- 其他的
农场动物药物市场 – 按动物类型
- 牲畜动物
- 马
农场动物药物市场 – 按给药途径
- 口服
- 肠外
- 主题
- 其他的
农场动物药物市场 – 按分销渠道
- 兽医医院
- 兽医诊所
- 药房和药店
- 其他的
农场动物药物市场 – 按地区划分
• 北美
- 我们
- 加拿大
- 墨西哥
• 欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
• 亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太其他地区
• 中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
• 南美洲和中美洲(SCAM)
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区
公司简介
- 菲布罗动物保健公司
- 硕腾公司
- 塞瓦
- 礼来
- 维克
- INTAS 制药有限公司
- Alembic 制药有限公司
- 勃林格殷格翰国际有限公司
- 默沙东动物保健
- 维托喹诺尔公司
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The oral segment dominated the global farm animal drugs market and accounted for the largest revenue share of 42.81% in 2021.
The veterinary hospitals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 36.70% in 2021.
The farm animal drugs market majorly consists of the players such PHIBRO ANIMAL HEALTH CORPORATION, Zoetis Inc., Ceva, Elanco, Virbac, INTAS PHARMACEUTICALS LTD., Alembic Pharmaceuticals Limited, Boehringer Ingelheim International GmbH, MSD Animal Health, and Vetoquinol SA among others.
The parasiticides segment dominated the global farm animal drugs market and held the largest revenue share of 26.88% in 2021.
The livestock animals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 90.77% in 2021
Key factors that are driving the growth of this market are the growing use of pain management drugs in farm animals, rising incidence of foodborne diseases and infections, and surging demand for quality pharmaceuticals and food security are expected to boost the market growth for the farm animal drugs over the years.
Drugs play a key role in maintaining the health of farm animals and improving the economic condition of farm producers. The need for better productivity has become important more, as the population are looking for nutritious and disease-free food products. The pharmacologically active compounds help prevent the passing of diseases from animals to humans. Farm animal’s health have been considerably shaped by the use of drugs. Farm animal drugs are medicines used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines are used as per strict requirements based on their essentiality to maintain the well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of the livestock industry across the world.
The List of Companies - Farm Animal Drugs Market
- PHIBRO ANIMAL HEALTH CORPORATION
- Zoetis Inc.
- Ceva
- Elanco
- Virbac
- INTAS PHARMACEUTICALS LTD.
- Alembic Pharmaceuticals Limited
- Boehringer Ingelheim International GmbH
- MSD Animal Health
- Vetoquinol SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.